Expression of cystatin C in human stomach neoplasms

Molecular Medicine Reports

Volumn 3, Issue 4, 2010, Pages 607-611

  Zeng, Qinghong ^a   Zhao, Yonggang ^a   Yang, Yuxian ^a   Chen, Xiao Xuan ^a   Wang, Geifei ^a   Zhang, Peng ^b   Cui, Youhong ^b   Su, Shaobo ^c   Li, Kangsheng ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cystatin C; Immunohistochemistry; Reverse transcriptase polymerase chain reaction; Stomach neoplasms

Indexed keywords

CYSTATIN C; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR;

EID: 77956704537     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000304     Document Type: Article

References (44)

1. Kumar S and Weaver VM: Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev 28: 113-127, 2009.
2. Erler JT and Weaver VM: Three-dimensional context regulation of metastasis. Clin Exp Metastasis 26: 35-49, 2009.
3. Bodenstine TM and Welch DR: Metastasis suppressors and the tumor microenvironment. Cancer Microenviron 1: 1-11, 2008.
4. Okegawa T, Pong RC, Li Y and Hsieh JT: The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol 51: 445-457, 2004. (Pubitemid 38969306)
5. Mareel M and Leroy A: Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83: 337-376, 2003. (Pubitemid 36382891)
6. Mizejewski GJ: Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222: 124-138, 1999. (Pubitemid 29514126)
7. Abrahamson M, Mason RW, Hansson H, Buttle DJ, Grubb A and Ohlsson K: Human Cystatin C role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J 273: 621-626, 1991.
8. Spiess E, Bruning A, Gack S, et al: Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level. J Histochem Cytochem 42: 917-929, 1994. (Pubitemid 24198450)
9. Kos J, Stabuc B, Schweiger A, et al: Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 3: 1815-1822, 1997.
10. Dohchin A, Suzuki JI, Seki H, Masutani M, Shiroto H and Kawakami Y: Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer 89: 482-487, 2000. (Pubitemid 30640094)
11. Jiborn T, Abrahamson M, Gadaleanu V, Lundwall A and Bjartell A: Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation. BJU Int 98: 189-196, 2006. (Pubitemid 43885530)
12. Strojan P, Svetic B, Smid L and Kos J: Serum cystatin C in patients with head and neck carcinoma. Clin Chim Acta 344: 155-161, 2004. (Pubitemid 38626150)
13. Dickinson DP: Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 13: 238-275, 2002.
14. Gocheva V, Zeng W, Ke D, et al: Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20: 543-556, 2006. (Pubitemid 43345321)
15. Hansen T, Unger RE, Gaumann A, et al: Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma. Mod Pathol 14: 1226-1231, 2001. (Pubitemid 33151164)
16. Nomura T and Katunuma N: Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 52: 1-9, 2005. (Pubitemid 40502564)
17. Frohlich E, Schlagenhauff B, Mohrle M, Weber E, Klessen C and Rassner G: Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer 91: 972-982, 2001. (Pubitemid 32198610)
18. Hansen T, Petrow PK, Gaumann A, et al: Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath. Mod Pathol 14: 318-324, 2001.
19. Yanamandra N, Gumidyala KV, Waldron KG, et al: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene 23: 2224-2230, 2004.
20. Lakka SS, Gondi CS, Yanamandra N, et al: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23: 4681-4689, 2004.
21. Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M and Rao JS: RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene 23: 8486-8496, 2004.
22. Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF and Rosenblum ML: Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg 83: 285-290, 1995.
23. Ledakis P, Tester WT, Rosenberg N, Romero-Fischmann D, Daskal I and Lah TT: Cathepsins D, B, and L in malignant human lung tissue. Clin Cancer Res 2: 561-568, 1996.
24. Hirai K, Yokoyama M, Asano G and Tanaka S: Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol 30: 680-686, 1999. (Pubitemid 29266728)
25. Abrahamson M, Olafsson I, Palsdottir A, et al: Structure and expression of the human cystatin C gene. Biochem J 268: 287-294, 1990.
26. Turk V and Bode W: The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 285: 213-219, 1991.
27. Newman DJ: Cystatin C. Ann Clin Biochem 39: 89-104, 2002.
28. Laterza OF, Price CP and Scott MG: Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48: 699-707, 2002.
29. Keppler D: Towards novel anti-cancer strategies based on cystatin function. Cancer Lett 235: 159-176, 2006.
30. Huh CG, Hakansson K, Nathanson CM, et al: Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol 52: 332-340, 1999.
31. Strojan P, Oblak I, Svetic B, Smid L and Kos J: Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis. Br J Cancer 90: 1961-1968, 2004.
32. Nishikawa H, Ozaki Y, Nakanishi T, et al: The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol Oncol 92: 881-886, 2004.
33. Petty RD, Kerr KM, Murray GI, et al: Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer. J Clin Oncol 24: 1729-1744, 2006.
34. Mulaomerovic A, Halilbasic A, Cickusic E, Zavasnik-Bergant T, Begic L and Kos J: Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma. Cancer Lett 248: 192-197, 2007.
35. Zinkin NT, Grall F, Bhaskar K, et al: Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res 14: 470-477, 2008.
36. Tumminello FM, Flandina C, Crescimanno M and Leto G: Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications. Biomed Pharmacother 62: 130-135, 2008.
37. Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ and Brunner N: Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res 6: 505-511, 2000. (Pubitemid 30111471)
38. Lignelid H, Collins VP and Jacobsson B: Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary. Acta Neuropathol 93: 494-500, 1997.
39. Lignelid H and Jacobsson B: Cystatin C in the human pancreas and gut: an immunohistochemical study of normal and neoplastic tissues. Virchows Arch A Pathol Anat Histopathol 421: 491-495, 1992.
40. Jacobsson B, Lignelid H and Bergerheim US: Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology 26: 559-564, 1995.
41. Wang B, Sun J, Kitamoto S, et al: Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 281: 6020-6029, 2006.
42. Sokol JP and Schiemann WP: Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. Mol Cancer Res 2: 183-195, 2004.
43. Sokol JP, Neil JR, Schiemann BJ and Schiemann WP: The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta. Breast Cancer Res 7: R844-R853, 2005.
44. Ogawa M, Jing H, Kitts DD, Nakai S and Nakamura S: In vitro anti-cancer activities in Caco-2 and HCT-116 cells of recombinant cystatin C prepared by a Pichia expression system. J Med Food 6: 317-322, 2003.